The PARADIGM project is proud to present its new paper “Evaluating the return on patient engagement initiatives in medicines research and development: A literature review”, published in the Journal of Health Expectations on 6 September.
The article was led by Lidewij Eva Vat from the Athena Institute at the Vrije Universiteit Amsterdam. Alzheimer Europe Project Officer, Ana Diaz was involved in the paper. Alzheimer Europe offers its congratulations to the PARADIGM team on this publication.
PARADIGM is a public‐private partnership and is co‐led by the European Patients’ Forum and the European Federation of Pharmaceutical Industries and Associations (EFPIA). PARADIGM is receiving funding from the Innovative Medicines Initiative Joint Undertaking 2. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA.